Obesity and plasma concentrations of alpha-tocopherol and beta-carotene in epileptic girls treated with valproate

Neuroendocrinology

Volumn 79, Issue 3, 2004, Pages 157-162

  Verrotti, Alberto ^a   Greco, Rita ^a   Latini, Giuseppe ^b   De Simone, Michele ^c   Chiarelli, Francesco ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Department of Pediatrics   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Tocopherol; Carotene; Clinical neuroendocrinology; Epilepsy; Obesity; Valproate

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; BETA CAROTENE; LOW DENSITY LIPOPROTEIN; VALPROIC ACID;

ARTICLE; ATHEROSCLEROSIS; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; OBESITY; OXIDATION; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SIDE EFFECT; TREATMENT WITHDRAWAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WEIGHT GAIN;

ADOLESCENT; ALPHA-TOCOPHEROL; ANTICONVULSANTS; ANTIOXIDANTS; BETA CAROTENE; BODY WEIGHT; CAROTENOIDS; CHILD; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; OBESITY; PROSPECTIVE STUDIES; VALPROIC ACID; WEIGHT GAIN;

EID: 2342478003     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077274     Document Type: Article

References (26)

1. Biton V, Mirza W, Montouris G: Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 2001;57:565-566.
2. Jallon P, Picard F: Bodyweight gain and anticonvulsants: A comparative review. Drug Saf 2001;24:969-978.
3. Verrotti A, Basciani F, Morresi S, De Martino M, Morgese G, Chiarelli F: Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid. Neurology 1999;53:230-232.
4. Isojärvi JIT, Astrup A, Gram L: Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 1996;39:579-584.
5. Kusunoki M, Yamamura T, Ichii S: The effect of sodium valproate on plasma somatostatin and insulin in humans. J Clin Endocrinol Metab 1988;67:1060-1063.
6. Verrotti A, Basciani F, De Simone M, Trotta D, Chiarelli F: Insulin resistance in epileptic girls who gain weight after therapy with valproic acid. J Child Neurol 2002;17:1-4.
7. Gey KF, Brubacher GB, Stahelin HB: Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr 1987;45:1368-1377.
8. Kuno T, Hozumi M, Morinobu T, Murata T, Mingci Z, Tamai H: Antioxidant vitamin levels in plasma and low density lipoprotein of obese girls. Free Rad Res 1997;28:81-86.
9. Wallström P, Wirfält E, Lahamann PH, Gulberg B, Janzon L, Berghund G: Serum concentrations of β-carotene and α-tocopherol are associated with diet, smoking, and general and central adiposity. Am J Clin Nutr 2001;73:777-785.
10. Decsi T, Molnar D, Koletzko B: Reduced plasma concentrations of alpha-tocopherol and beta-carotene in obese boys. J Pediatr 1997;130:653-655.
11. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G: Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 1991;53:314-321.
12. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989;30:389-399.
13. Verrotti A, Domizio S, Angelozzi B, Sabatino G, Morgese G, Chiarelli F: Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants. J Paediatr Child Health 1997;33:242-245.
14. Göbel Y, Schaffer C, Koletzko B: Simultaneous determination of low plasma concentrations of retinol and tocopherols in preterm infants by a HPLC micromethod. J Chromatogr, in press.
15. Thurnham DI, Davies JA, Crump BJ, Situnayake RD, Davis M: The use of different lipids to express serum tocopherol: Lipid ratios for the measurement of vitamin E status. Ann Clin Biochem 1986;23:514-520.
16. Borgos AM, Wartanowicz M, Ziemlanski S: Blood vitamin and lipid levels in overweight and obese women. Eur J Clin Nutr 1992;46:803-808.
17. Barker DJP, Winter PD, Osmond C: Weight in infancy and death from ischaemic heart disease. Lancet 1989;ii:557-580.
18. Barker DJP, Bull AR, Osmond C, Simmond SJ: Fetal and placental size and risk of hypertension in adult life. BMJ 1990;301:259-262.
19. Lillioia S, Nyomba BL, Saad MF: Exaggerated early insulin release and insulin resistance in diabetes-prone population: A metabolic comparison of Pima Indians and Caucasian. J Clin Endocrinol Metab 1991;73:866-876.
20. Saad MF, Knowler WC, Pettitt DJ: A two-step model for development of noninsulin dependent diabetes. Am J Med 1991;90:229-235.
21. Haffner SM, Stern MP, Hazuda HP: Increased insulin concentrations in nondiabetic offspring of diabetic parents. N Engl J Med 1988;319: 1297-1301.
22. Charles MA, Fontbonne A, Thibult N: Risk factors for NIDDM in white population: Paris prospective study. Diabetes 1991;40:796-799.
23. Bergman RN: Towards physiological understanding of glucose tolerance - minimal model approach. Diabetes 1989;38:1512-1527.
24. Bergman RN, Steil GM, Bradley DC, Watanabe RM: Modeling of insulin action in vivo. Annu Rev Physiol 1992;54:861-883.
25. Verrotti A, Basciani F, Domizio S, Sabatino G, Morgese G, Chiarelli F: Serum lipids and lipoproteins in patients treated with antiepileptic drugs. Pediatr Neurol 1998;19:364-367.
26. Heldenberg D, Harel S, Holtzman M, Levtow O, Tamir I: The effect of chronic anticonvulsant therapy on serum lipids and lipoproteins in epileptic children. Neurology 1983;33:510-512.